Filing Details

Accession Number:
0001127602-20-030141
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-30 19:31:01
Reporting Period:
2020-11-25
Accepted Time:
2020-11-30 19:31:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1451535 R Curt Hartman C/O Conmed Corp
525 French Road
Utica NY 13502
President, Ceo And Chair Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-25 136,000 $39.87 240,051 No 4 M Direct
Common Stock Disposition 2020-11-25 92,194 $106.14 147,857 No 4 F Direct
Common Stock Disposition 2020-11-25 2,512 $105.40 145,345 No 4 S Direct
Common Stock Disposition 2020-11-27 596 $105.01 144,749 No 4 S Direct
Common Stock Disposition 2020-11-30 5,192 $101.69 139,557 No 4 S Direct
Common Stock Disposition 2020-11-30 1,700 $102.74 137,857 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2020-11-25 136,000 $0.00 136,000 $39.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,000 2026-03-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.84 to $105.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.34 to $102.25. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.355 to $103.36. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
  4. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.